F. Mignolet

发表

In Vitro Screening of the Antibacterial and Anti-Candida Properties of Crushed Nonantimicrobial Drugs Frequently Prescribed in Nursing Homes.

M. Chevalier, I. Prêcheur, J. Lamure, 2018, Research in gerontological nursing.

Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancer.

L. Beex, A. Hermus, Q. V. van Hoesel, 1992, European journal of cancer.

Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion

D. Lacombe, M. Tubiana-Hulin, C. Rose, 1999, British Journal of Cancer.

PP-8-7 Assessment of response in bone within an EORTC randomised trial of bisphosphonate treatment (10924)

D. Lacombe, J. Nortier, C. Rose, 1996 .

Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group.

R. Paridaens, R. Sylvester, J. Julien, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: Preliminary results of a double-blind randomized study of the eortic breast cancer cooperative group

J. Klijn, R. Paridaens, R. Sylvester, 1990, Journal of Steroid Biochemistry and Molecular Biology.

Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881

M. Piccart, L. Mauriac, J. Jassem, 1998 .

Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.

E van der Schueren, R Sylvester, H. Bartelink, 1992, Journal of the National Cancer Institute. Monographs.

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.

J. Peterse, H. Bartelink, I. Fentiman, 1999, European journal of cancer.

Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study.

M. Piccart, I. Fentiman, R. Paridaens, 1996, European journal of cancer.

Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.

T. Delozier, C. V. D. van de Velde, J. Julien, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas

D. Áfra, J. Hildebrand, T. Sahmoud, 1994, Neurology.

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853

J. Peterse, H. Bartelink, I. Fentiman, 2000, The Lancet.

Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.

J. Klijn, M. Piccart, L. Mauriac, 2000, Journal of the National Cancer Institute.

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.

H. Bartelink, I. Fentiman, R. Sylvester, 1992, European journal of cancer.

Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG).

N K Aaronson, H. Bartelink, I. Fentiman, 1998, European journal of cancer.

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.

C. V. D. van de Velde, J. Julien, J P Julien, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PP-8-1 Combined estroyen suppression and receptor (ER) blockade by buserelin (LHRH-A) and tamoxifen (TAM) in premenopausal metastatic breast cancer: Preliminary results of a 3-arm randomized study (EORTC 10881)

J. Klijn, M. Piccart, J. Garcia-conde, 1996 .

a of Assessment of bone response to systemic therapy in an trial: preliminary with the use of cross-link

D. Lacombe, C. Rose, R. Coleman, 2021 .